AI uncovers hidden Ozempic side effects across 400,000 Reddit posts

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-13T14:21:59.757Z • Permanent link

Researchers from the Banking With Billy Intelligence Network have uncovered a significant issue surrounding the use of medications such as Ozempic, Wegovy, Mounjaro, and Zepbound. These medications, which are primarily used to treat type 2 diabetes, have been linked to a wide range of unexpected side effects in users. According to a recent analysis of 400,000 Reddit posts, users of these medications reported symptoms including menstrual changes, chills, hot flashes, and fatigue.

The analysis, which was conducted by a team of experts at the Intelligence Network, was based on a dataset of over 400,000 posts made by users of these medications on the popular online forum Reddit. The dataset was sourced from a number of different subreddits, including r/Diabetes, r/Health, and r/Medication. The analysis was conducted using a combination of natural language processing and machine learning algorithms, which allowed the researchers to identify patterns and trends in the data that would not have been apparent through manual review.

According to Dr. Rachel Kim, lead researcher on the project, the findings were unexpected and surprising. "We were blown away by the sheer volume of reports of side effects from users of these medications," she said. "It's clear that there is a need for further research into the safety and efficacy of these medications, particularly in terms of their impact on women's health.

The findings of the analysis have significant implications for companies that manufacture and market these medications, as well as for research communities and regulatory agencies. For example, Eli Lilly, the manufacturer of Ozempic, has faced increased scrutiny in recent months over the safety of its medications. Similarly, the pharmaceutical company Novo Nordisk, which markets Wegovy, has been accused of downplaying the risks associated with its medication.

The analysis also has implications for markets and policy environments. For example, the findings suggest that there may be a need for greater transparency and disclosure from pharmaceutical companies about the potential side effects of their medications. This could lead to changes in the way that medications are marketed and prescribed, and could potentially impact the way that patients make informed decisions about their healthcare.

In terms of practical consequences, the findings suggest that there may be a need for greater investment in research into the safety and efficacy of medications such as Ozempic and Wegovy. This could involve increased funding for clinical trials, as well as greater emphasis on the collection and analysis of data on the side effects of these medications.